BriaCell Therapeutics Corp. (NASDAQ:BCTXW) Sees Large Increase in Short Interest

BriaCell Therapeutics Corp. (NASDAQ:BCTXW) saw a large growth in short interest in the month of December. As of December 31st, there was short interest totaling 5,328 shares, a growth of 63.1% from the December 15th total of 3,266 shares. Based on an average daily volume of 89,435 shares, the days-to-cover ratio is currently 0.1 days. Based on an average daily volume of 89,435 shares, the days-to-cover ratio is currently 0.1 days.

BriaCell Therapeutics Stock Performance

Shares of NASDAQ:BCTXW opened at $0.02 on Friday. The business has a 50 day simple moving average of $0.05 and a two-hundred day simple moving average of $0.04. BriaCell Therapeutics has a 1 year low of $0.01 and a 1 year high of $0.25.

BriaCell Therapeutics Company Profile

BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on the development of novel immunotherapeutic treatments for breast cancer and other solid tumors. The company’s research strategy centers on harnessing the body’s immune system to recognize and attack cancer cells, with an emphasis on off-the-shelf allogeneic platforms that can be readily administered without the need for patient-specific manufacturing.

The company’s lead candidate, Bria-IMT, is derived from a human breast tumor cell line engineered to express immune-stimulatory molecules designed to trigger both innate and adaptive anti-tumor responses.